Clinical Trial

GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women

Study acronym: GLOW
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study is designed with the interest to learn on the effects of estrogen levels and how it affects body compositions and muscle function in midlife women who are taking a GLP-1RA for weight loss.
Protocol Amendment History 1 change
critical Enrollment closed, study ongoing 2026-08-08
Trial Details
NCT Number NCT07422987
Lead Sponsor University of Kansas Medical Center
Conditions Body Composition, Muscle Function, GLP-1, Estrogen Level
Enrollment 50 participants
Start Date 2026-02-12
Primary Completion 2027-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-07